ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544,809 | -18.5% | 56,920 | -7.7% | 0.01% | -14.3% |
| Q2 2023 | $1,895,582 | -14.6% | 61,665 | +0.0% | 0.01% | -30.0% |
| Q1 2023 | $2,220,853 | -14.4% | 61,639 | -6.1% | 0.01% | -23.1% |
| Q4 2022 | $2,594,014 | +0.6% | 65,638 | +2.3% | 0.01% | -13.3% |
| Q3 2022 | $2,578,000 | +21383.3% | 64,154 | +22175.7% | 0.02% | – |
| Q2 2022 | $12,000 | +20.0% | 288 | +11.2% | 0.00% | – |
| Q1 2022 | $10,000 | +66.7% | 259 | +76.2% | 0.00% | – |
| Q4 2021 | $6,000 | -14.3% | 147 | -29.0% | 0.00% | – |
| Q3 2021 | $7,000 | – | 207 | +2857.1% | 0.00% | – |
| Q2 2021 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |